Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Adults with common variable immunodeficiency: a single-center experience.

Muşabak UH, Demirel F, Yeşillik S, Baysan A, Selçuk A, Kartal Ö, Güleç M, Öktenli Ç, Şener O.

Turk J Med Sci. 2017 Feb 27;47(1):1-12. doi: 10.3906/sag-1503-22.

PMID:
28263469
2.

Increased frequency of Mediterranean fever gene variants in multiple myeloma.

Celik S, Tangi F, Oktenli C.

Oncol Lett. 2014 Oct;8(4):1735-1738. Epub 2014 Aug 4.

3.

Increased acylation stimulating protein levels in young obese males is correlated with systemic markers of oxidative stress.

Celik S, Tangi F, Kilicaslan E, Sanisoglu YS, Oktenli C, Top C.

Obesity (Silver Spring). 2013 Aug;21(8):1613-7. doi: 10.1002/oby.20175. Epub 2013 May 13.

4.

High Frequency of Inherited Variants in the MEFV Gene in Acute Lymphocytic Leukemia.

Sayan O, Kilicaslan E, Celik S, Tangi F, Erikci AA, Ipcioglu O, Sanisoglu YS, Nalbant S, Oktenli C.

Indian J Hematol Blood Transfus. 2011 Sep;27(3):164-8. doi: 10.1007/s12288-011-0095-x. Epub 2011 Jul 21.

5.

Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males?

Ozari HO, Oktenli C, Celik S, Tangi F, Ipcioglu O, Terekeci HM, Top C, Uzun M, Sanisoglu YS, Nalbant S.

J Clin Ultrasound. 2012 Jul-Aug;40(6):335-40. doi: 10.1002/jcu.21927. Epub 2012 Apr 25.

PMID:
22532370
6.

High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?

Oktenli C, Celik S.

Int J Hematol. 2012 Apr;95(4):380-5. doi: 10.1007/s12185-012-1061-6. Epub 2012 Mar 28. Review.

PMID:
22453916
7.

Frequency of inherited variants in the MEFV gene in myelodysplastic syndrome and acute myeloid leukemia.

Celik S, Oktenli C, Kilicaslan E, Tangi F, Sayan O, Ozari HO, Ipcioglu O, Sanisoglu YS, Terekeci MH, Erikci AA.

Int J Hematol. 2012 Mar;95(3):285-90. doi: 10.1007/s12185-012-1022-0. Epub 2012 Feb 18.

PMID:
22351163
8.

Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia.

Ozturk A, Kucukardali Y, Tangi F, Erikci A, Uzun G, Bashekim C, Sen H, Terekeci H, Narin Y, Ozyurt M, Ozkan S, Sayan O, Rodop O, Nalbant S, Sıldıroglu O, Yalnız FF, Senkal IV, Sabuncu H, Oktenli C.

J Diabetes Complications. 2012 Jan-Feb;26(1):29-33. doi: 10.1016/j.jdiacomp.2011.11.007. Epub 2012 Jan 11.

PMID:
22240264
9.

Increased iron and oxidative stress are separately related to cognitive decline in elderly.

Umur EE, Oktenli C, Celik S, Tangi F, Sayan O, Sanisoglu YS, Ipcioglu O, Terekeci HM, Top C, Nalbant S, Kucukardali Y.

Geriatr Gerontol Int. 2011 Oct;11(4):504-9. doi: 10.1111/j.1447-0594.2011.00694.x. Epub 2011 Mar 30.

PMID:
21447135
10.

The rate of MEFV gene mutations in hematolymphoid neoplasms.

Celik S, Erikci AA, Tunca Y, Sayan O, Terekeci HM, Umur EE, Torun D, Tangi F, Top C, Oktenli C.

Int J Immunogenet. 2010 Oct;37(5):387-91. doi: 10.1111/j.1744-313X.2010.00938.x. Epub 2010 May 27.

PMID:
20518828
11.

High frequency of MEFV gene mutations in patients with myeloid neoplasm.

Oktenli C, Sayan O, Celik S, Erikci AA, Tunca Y, Terekeci HM, Umur EE, Sanisoglu YS, Torun D, Tangi F, Sahan B, Nalbant S.

Int J Hematol. 2010 Jun;91(5):758-61. doi: 10.1007/s12185-010-0577-x. Epub 2010 May 1.

PMID:
20437121
12.

The vasoactive intestinal polypeptide (VIP) levels at the patients with ankylosing spondylitis and its association with inflammation markers.

Nalbant S, Cagiltay E, Sahan B, Terekeci HM, Oktenli C.

Rheumatol Int. 2011 Sep;31(9):1143-6. doi: 10.1007/s00296-010-1417-2. Epub 2010 Mar 26.

PMID:
20340024
13.

Relationship between anaemia and cognitive functions in elderly people.

Terekeci HM, Kucukardali Y, Onem Y, Erikci AA, Kucukardali B, Sahan B, Sayan O, Celik S, Gulec M, Sanisoglu YS, Nalbant S, Top C, Oktenli C.

Eur J Intern Med. 2010 Apr;21(2):87-90. doi: 10.1016/j.ejim.2009.12.005. Epub 2009 Dec 29.

PMID:
20206877
14.

Risk assessment study of the pressure ulcers in intensive care unit patients.

Terekeci H, Kucukardali Y, Top C, Onem Y, Celik S, Oktenli C.

Eur J Intern Med. 2009 Jul;20(4):394-7. doi: 10.1016/j.ejim.2008.11.001. Epub 2008 Dec 6.

PMID:
19524181
15.

Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity.

Bulucu F, Ocal R, Karadurmus N, Sahin M, Kenar L, Aydin A, Oktenli C, Koc B, Inal V, Yamanel L, Yaman H.

Biol Trace Elem Res. 2009 Dec;132(1-3):184-96. doi: 10.1007/s12011-009-8377-y.

PMID:
19396405
16.

Albumin, hemoglobin, body mass index, cognitive and functional performance in elderly persons living in nursing homes.

Onem Y, Terekeci H, Kucukardali Y, Sahan B, Solmazgül E, Senol MG, Nalbant S, Sayan O, Top C, Oktenli C.

Arch Gerontol Geriatr. 2010 Jan-Feb;50(1):56-9. doi: 10.1016/j.archger.2009.01.010. Epub 2009 Feb 23.

PMID:
19233487
17.

The relationship between adiponectin levels and degree of proteinuria in patients with nephrotic and non-nephrotic proteinuria.

Oguz Y, Yilmaz MI, Acikel C, Eyileten T, Caglar K, Oktenli C, Yenicesu M, Vural A.

Ren Fail. 2009;31(1):29-35. doi: 10.1080/08860220802546461.

PMID:
19142807
18.

Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.

Terekeci HM, Senol MG, Top C, Sahan B, Celik S, Sayan O, Kucukardali Y, Ipcioglu O, Cagiltay E, Oktenli C, Ozata M.

Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):119-23. doi: 10.1055/s-0028-1085425. Epub 2008 Dec 3.

PMID:
19053023
19.

The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis.

Ercin CN, Yesilova Z, Korkmaz A, Ozcan A, Oktenli C, Uygun A.

Dig Dis Sci. 2009 Jan;54(1):75-9. doi: 10.1007/s10620-008-0498-1. Epub 2008 Oct 30.

PMID:
18972208
20.

Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?

Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S, Tapan S, Kucukardali Y, Sanisoglu YS, Solmazgul E, Sahan B, Sayan O.

J Rheumatol. 2008 Oct;35(10):2024-9. Epub 2008 Sep 1.

PMID:
18785307
21.

Analyses of subjects with hypokalemic metabolic alkolosis, Gitelman's and Bartter's syndrome.

Onem Y, Kucukardali Y, Sahan B, Atasoyu EM, Ipcioğlu O, Terekeci H, Solmazgul E, Top C, Oktenli C.

Ren Fail. 2008;30(7):691-4. doi: 10.1080/08860220802212718.

PMID:
18704817
22.

Do the changes in the serum levels of IL-2, IL-4, TNFalpha, and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis?

Kilciler G, Musabak U, Bagci S, Yesilova Z, Tuzun A, Uygun A, Gulsen M, Oren S, Oktenli C, Karaeren N.

Clin Dev Immunol. 2008;2008:481560. doi: 10.1155/2008/481560.

23.

Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.

Bulucu F, Oktenli C, Kenar L, Ocal R, Koc B, Inal V, Yamanel L, Yaman H, Sanisoglu YS, Aydin A.

J Nephrol. 2008 Jul-Aug;21(4):576-83.

PMID:
18651549
24.

Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters.

Terekeci HM, Ulusoy ER, Kucukarslan NM, Nalbant S, Oktenli C.

Rheumatol Int. 2008 Oct;28(12):1239-43. doi: 10.1007/s00296-008-0648-y. Epub 2008 Jul 23.

PMID:
18648816
25.

Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy.

Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, Sanisoglu SY, Yesilova Z, Ozmenler N, Ozsahin A, Sengul A.

Clin Dev Immunol. 2007;2007:76396. doi: 10.1155/2007/76396.

26.

Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).

Ozgurtas T, Oktenli C, Dede M, Tapan S, Kenar L, Sanisoglu SY, Yesilova Z, Yenen MC, Erbil MK, Baser I.

Atherosclerosis. 2008 Oct;200(2):336-44. doi: 10.1016/j.atherosclerosis.2007.12.054. Epub 2008 Feb 20.

PMID:
18281049
27.

Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.

Oktenli C, Ozgurtas T, Dede M, Sanisoglu YS, Yenen MC, Yesilova Z, Kenar L, Kurt YG, Baser I, Smith J, Cianflone K.

Gynecol Endocrinol. 2007 Dec;23(12):710-5.

PMID:
18075846
28.

Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model.

Bulucu F, Oktenli C, Kenar L, Koc B, Ocal R, Karadurmus N, Inal V, Yamanel L, Sanisoglu YS, Aydin A.

Int J Toxicol. 2007 Nov-Dec;26(6):525-32.

PMID:
18066968
29.

The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study.

Koc B, Oktenli C, Bulucu F, Karadurmus N, Sanisoglu SY, Gul D.

J Rheumatol. 2007 Oct;34(10):2070-5. Epub 2007 Aug 1.

PMID:
17696266
30.

ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease.

Caglar K, Yilmaz MI, Sonmez A, Cakir E, Kaya A, Acikel C, Eyileten T, Yenicesu M, Oguz Y, Bilgi C, Oktenli C, Vural A, Zoccali C.

Kidney Int. 2006 Aug;70(4):781-7. Epub 2006 Jul 5.

31.

Persistent mediastinal and axillary lymph node tuberculosis in a renal transplant patient with successful outcome.

Oguz Y, Yilmaz MI, Eyileten T, Caglar K, Yenicesu M, Kaya A, Tasar M, Saglam M, Doganci L, Gulec B, Oner K, Oktenli C, Vural A.

Transplant Proc. 2006 Jun;38(5):1336-40.

PMID:
16797296
32.

Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey.

Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M.

BMC Public Health. 2006 Apr 10;6:92.

33.

Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque.

Karaduman M, Oktenli C, Musabak U, Sengul A, Yesilova Z, Cingoz F, Olgun A, Sanisoglu SY, Baysan O, Yildiz O, Taslipinar A, Tatar H, Kutlu M, Ozata M.

Clin Exp Immunol. 2006 Mar;143(3):452-7.

34.

Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques.

Karaduman M, Sengul A, Oktenli C, Pekel A, Yesilova Z, Musabak U, Sanisoglu SY, Gunay C, Baysan O, Kocar IH, Tatar H, Ozata M.

Clin Endocrinol (Oxf). 2006 Feb;64(2):196-202.

PMID:
16430720
35.

Evaluation of insulin sensitivity in patients with Klinefelter's syndrome: a hyperinsulinemic euglycemic clamp study.

Yesilova Z, Oktenli C, Sanisoglu SY, Musabak U, Cakir E, Ozata M, Dagalp K.

Endocrine. 2005 Jun;27(1):11-5.

PMID:
16077165
36.

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease.

Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, Sanisoglu SY, Erdil A, Ates Y, Aslan M, Musabak U, Erbil MK, Karaeren N, Dagalp K.

Am J Gastroenterol. 2005 Apr;100(4):850-5.

PMID:
15784031
37.

Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with insulin resistance.

Yesilova Z, Ozata M, Oktenli C, Bagci S, Ozcan A, Sanisoglu SY, Uygun A, Yaman H, Karaeren N, Dagalp K.

Am J Gastroenterol. 2005 Apr;100(4):842-9.

PMID:
15784030
38.

Outer hair cell activity of the cochlea in patients with iron deficiency anemia.

Cetin T, Yetiser S, Cekin E, Durmus C, Nevruz O, Oktenli C.

Auris Nasus Larynx. 2004 Dec;31(4):389-94.

PMID:
15571912
39.

Does immune activation continue during an attack-free period in familial Mediterranean fever?

Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, Bagci S.

Clin Exp Immunol. 2004 Dec;138(3):526-33.

40.

Unusual features in a patient with neurofibromatosis type 1: multiple subcutaneous lipomas, a juvenile polyp in ascending colon, congenital intrahepatic portosystemic venous shunt, and horseshoe kidney.

Oktenli C, Gul D, Deveci MS, Saglam M, Upadhyaya M, Thompson P, Consoli C, Kocar IH, Pilarski R, Zhou XP, Eng C.

Am J Med Genet A. 2004 Jun 15;127A(3):298-301.

PMID:
15150783
41.

Effect of supraphysiologic doses of testosterone on fasting plasma total homocysteine concentrations in men with Klinefelter's syndrome.

Yesilova Z, Ozata M, Oktenli C, Sanisoglu SY, Erbil MK, Dagalp K.

Fertil Steril. 2004 May;81(5):1278-82.

PMID:
15136090
42.

Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy?

Yesilova Z, Pay S, Oktenli C, Musabak U, Saglam K, Sanisoglu SY, Dagalp K, Erbil MK, Kocar IH.

Rheumatol Int. 2005 Aug;25(6):423-8. Epub 2004 Apr 1.

PMID:
15057566
43.

Transient hypogonadotrophic hypogonadism in males with acute toxoplasmosis: suppressive effect of interleukin-1 beta on the secretion of GnRH.

Oktenli C, Doganci L, Ozgurtas T, Araz RE, Tanyuksel M, Musabak U, Sanisoglu SY, Yesilova Z, Erbil MK, Inal A.

Hum Reprod. 2004 Apr;19(4):859-66. Epub 2004 Feb 27.

PMID:
14990538
44.

Renal tubular dysfunction in beta-thalassemia minor.

Cetin T, Oktenli C, Ozgurtas T, Yenicesu M, Sanisoglu SY, Oguz Y, Yildiz O, Kurt I, Musabak U, Bulucu F, Kocar IH.

Am J Kidney Dis. 2003 Dec;42(6):1164-8.

PMID:
14655187
45.

The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.

Oguz Y, Oktenli C, Ozata M, Ozgurtas T, Sanisoglu Y, Yenicesu M, Vural A, Bulucu F, Kocar IH.

J Endocrinol Invest. 2003 Jul;26(7):609-15.

PMID:
14594109
46.

A large deletion (1.5 Mb) encompassing the neurofibromatosis type 1 (NF1) gene in a patient with sporadic NF1 associated with dysmorphism, mental retardation, and unusual ocular and skeletal features.

Oktenli C, Saglam M, Demirbas S, Thompson P, Upadhyaya M, Consoli C, Ulucan H, Koz C, Durukan AH, Bozkurt A, Koc B, Kocar IH, Gul D.

Clin Dysmorphol. 2003 Jul;12(3):199-201.

PMID:
14564162
47.

Gonadotropin treatment increases homocysteine levels in idiopathic hypogonadotropic hypogonadism: an indirect effect mediated by changes in body composition.

Oktenli C, Yesilova Z, Ozata M, Yaman H, Tuzun A, Dundar S, Sanisoglu SY, Musabak U, Erbil MK, Dagalp K.

J Endocrinol. 2003 Oct;179(1):35-9.

PMID:
14529563
48.

Acute pyelonephritis causing acute renal allograft dysfunction.

Oguz Y, Doganci L, Bulucu F, Can C, Oktenli C, Yenicesu M, Vural A.

Int Urol Nephrol. 2002;34(3):299-301.

PMID:
12899217
49.
50.

Supplemental Content

Loading ...
Support Center